163 related articles for article (PubMed ID: 23008774)
1. Cardiomyopathy-Related Mutations in Cardiac Troponin C, L29Q and G159D, Have Divergent Effects on Rat Cardiac Myofiber Contractile Dynamics.
Gollapudi SK; Chandra M
Biochem Res Int; 2012; 2012():824068. PubMed ID: 23008774
[TBL] [Abstract][Full Text] [Related]
2. Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes?
Dweck D; Hus N; Potter JD
J Biol Chem; 2008 Nov; 283(48):33119-28. PubMed ID: 18820258
[TBL] [Abstract][Full Text] [Related]
3. Structural kinetics of cardiac troponin C mutants linked to familial hypertrophic and dilated cardiomyopathy in troponin complexes.
Dong WJ; Xing J; Ouyang Y; An J; Cheung HC
J Biol Chem; 2008 Feb; 283(6):3424-3432. PubMed ID: 18063575
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial dilated cardiomyopathy, studied in explanted heart muscle.
Dyer EC; Jacques AM; Hoskins AC; Ward DG; Gallon CE; Messer AE; Kaski JP; Burch M; Kentish JC; Marston SB
Circ Heart Fail; 2009 Sep; 2(5):456-64. PubMed ID: 19808376
[TBL] [Abstract][Full Text] [Related]
5. The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation.
Biesiadecki BJ; Kobayashi T; Walker JS; Solaro RJ; de Tombe PP
Circ Res; 2007 May; 100(10):1486-93. PubMed ID: 17446435
[TBL] [Abstract][Full Text] [Related]
6. Familial hypertrophic cardiomyopathy related cardiac troponin C L29Q mutation alters length-dependent activation and functional effects of phosphomimetic troponin I*.
Li AY; Stevens CM; Liang B; Rayani K; Little S; Davis J; Tibbits GF
PLoS One; 2013; 8(11):e79363. PubMed ID: 24260207
[TBL] [Abstract][Full Text] [Related]
7. Molecular Effects of cTnC DCM Mutations on Calcium Sensitivity and Myofilament Activation-An Integrated Multiscale Modeling Study.
Dewan S; McCabe KJ; Regnier M; McCulloch AD; Lindert S
J Phys Chem B; 2016 Aug; 120(33):8264-75. PubMed ID: 27133568
[TBL] [Abstract][Full Text] [Related]
8. Familial hypertrophic cardiomyopathy-related cardiac troponin C mutation L29Q affects Ca2+ binding and myofilament contractility.
Liang B; Chung F; Qu Y; Pavlov D; Gillis TE; Tikunova SB; Davis JP; Tibbits GF
Physiol Genomics; 2008 Apr; 33(2):257-66. PubMed ID: 18285522
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
Parvatiyar MS; Pinto JR
Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
[TBL] [Abstract][Full Text] [Related]
10. Changes in the dynamics of the cardiac troponin C molecule explain the effects of Ca
Stevens CM; Rayani K; Singh G; Lotfalisalmasi B; Tieleman DP; Tibbits GF
J Biol Chem; 2017 Jul; 292(28):11915-11926. PubMed ID: 28533433
[TBL] [Abstract][Full Text] [Related]
11. Dilated Cardiomyopathy Mutation (R134W) in Mouse Cardiac Troponin T Induces Greater Contractile Deficits against α-Myosin Heavy Chain than against β-Myosin Heavy Chain.
Gollapudi SK; Chandra M
Front Physiol; 2016; 7():443. PubMed ID: 27757084
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophic cardiomyopathy mutation in cardiac troponin T (R95H) attenuates length-dependent activation in guinea pig cardiac muscle fibers.
Mickelson AV; Chandra M
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1180-H1189. PubMed ID: 28842439
[TBL] [Abstract][Full Text] [Related]
13. A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.
Parvatiyar MS; Landstrom AP; Figueiredo-Freitas C; Potter JD; Ackerman MJ; Pinto JR
J Biol Chem; 2012 Sep; 287(38):31845-55. PubMed ID: 22815480
[TBL] [Abstract][Full Text] [Related]
14. The structural and functional effects of the familial hypertrophic cardiomyopathy-linked cardiac troponin C mutation, L29Q.
Robertson IM; Sevrieva I; Li MX; Irving M; Sun YB; Sykes BD
J Mol Cell Cardiol; 2015 Oct; 87():257-69. PubMed ID: 26341255
[TBL] [Abstract][Full Text] [Related]
15. The cardiac troponin C mutation Leu29Gln found in a patient with hypertrophic cardiomyopathy does not alter contractile parameters in skinned murine myocardium.
Neulen A; Stehle R; Pfitzer G
Basic Res Cardiol; 2009 Nov; 104(6):751-60. PubMed ID: 19506933
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Ca2+ binding of cardiac troponin reduces sarcomere length dependence of contractile activation independently of strong crossbridges.
Korte FS; Feest ER; Razumova MV; Tu AY; Regnier M
Am J Physiol Heart Circ Physiol; 2012 Oct; 303(7):H863-70. PubMed ID: 22865385
[TBL] [Abstract][Full Text] [Related]
17. Dilated Cardiomyopathy Mutations and Phosphorylation disrupt the Active Orientation of Cardiac Troponin C.
Mahmud Z; Dhami PS; Rans C; Liu PB; Hwang PM
J Mol Biol; 2021 Jun; 433(13):167010. PubMed ID: 33901537
[TBL] [Abstract][Full Text] [Related]
18. Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C.
Schmidtmann A; Lindow C; Villard S; Heuser A; Mügge A; Gessner R; Granier C; Jaquet K
FEBS J; 2005 Dec; 272(23):6087-97. PubMed ID: 16302972
[TBL] [Abstract][Full Text] [Related]
19. The tropomyosin binding region of cardiac troponin T modulates crossbridge recruitment dynamics in rat cardiac muscle fibers.
Gollapudi SK; Gallon CE; Chandra M
J Mol Biol; 2013 May; 425(9):1565-81. PubMed ID: 23357173
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic Cardiomyopathy Cardiac Troponin C Mutations Differentially Affect Slow Skeletal and Cardiac Muscle Regulation.
Veltri T; Landim-Vieira M; Parvatiyar MS; Gonzalez-Martinez D; Dieseldorff Jones KM; Michell CA; Dweck D; Landstrom AP; Chase PB; Pinto JR
Front Physiol; 2017; 8():221. PubMed ID: 28473771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
